Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Gate Bioscience closes $65M Series B to advance molecular gates, oral drugs that eliminate disease proteins, into clinical trials for CNS/inflammation
-
NeXtGen Biologics and Lovell® Government Services Partner to Bring Innovative Advanced Wound Care Technology to Federal Healthcare Systems
-
NeXtGen Biologics Successfully Completes First FDA Audit with Zero 483 Observations
-
Dreamdata, the leading B2B Marketing Platform for the AI era, today announced it has closed a $55 million Series B funding round led by PeakSpan Capital.
-
Kailera Therapeutics announced a $600M Series B financing led by new investor Bain Capital Private Equity to support its late-stage obesity portfolio.
-
NeXtGen Biologics Announces Issuance Of A Third New Patent Covering Axolotl-Derived Technology
-
Aleph raises $29M Series B led by Khosla Ventures to expand its AI-native FP&A platform, empowering finance teams with faster, smarter decision-making.
-
Funding combines equity investment and convertible loanFocus on best-in-class, clinical-stage peanut allergen neutralizing antibody Further potential for developing Mabylon’s discovery and...
-
SNIPR Biome today announced the close of a EUR 35 million Series B financing round addressing antimicrobial resistance and infectious disease.
-
Molecule Software, the provider of the market’s most advanced energy trading risk management (ETRM) platform, has completed its Series B funding round.